Abstract
For over 30 years, investigators have used the simple but non-validated classification criteria suggested by Moll and Wright. Several authors have suggested modifications to these but most remain unvalidated or require human leukocyte antigen analysis. Now, a worldwide initiative has developed new criteria which include both clinical and radiological features. These will require further study before they are fully adopted but their improved performance should result in less variation between study cohorts. The recurring question of disease heterogeneity continues to occupy researchers in this field. Despite recent pleas to abandon the original five sub-groups, a case can be made for retaining at least the two sub-groups of peripheral and axial disease and, possibly, splitting the peripheral disease into oligo- and poly-arthritis.
References
Helliwell PS, Porter G, Taylor WJ (2007) Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 66(1):113–117
McGonagle D, Conaghan PG, Emery P (1999) Psoriatic arthritis: a unified concept twenty years on [see comment][erratum appears in Arthritis Rheum 1999 Sep;42(9):1997]. Arthritis Rheum 42(6):1080–1086
Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D, Roth J et al (2005) Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 7(3):R569–R580
Veale DJ, Ritchlin C, FitzGerald O (2005) Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 64(Suppl 2):ii26–ii29
Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41(6):1103–1110
Sihvonen S, Korpela M, Laippala P, Mustonen J, Pasternack A (2004) Death rates and causes of death in patients with rheumatoid arthritis: a population-based study. Scand J Rheumatol 33(4):221–227
Gorter S, van der Heijde DM, van der Linden S, Houben H, Rethans JJ, Scherpbier AJ et al (2002) Psoriatic arthritis: performance of rheumatologists in daily practice. Ann Rheum Dis 61(3):219–224
Symmons DP, Lunt M, Watkins G, Helliwell P, Jones S, McHugh N et al (2006) Developing classification criteria for peripheral joint psoriatic arthritis Step. I. Establishing whether the rheumatologist’s opinion on the diagnosis can be used as the “gold standard”. J Rheumatol 33(3):552–557
Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3(1):55–78
Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med 62(238):127–141
Bennett RM (1979) Psoriatic arthritis, 9th edn. Lea & Febiger, Philadelphia
Vasey F, Espinoza LR (1987) Psoriatic arthropathy. Grune & Stratton, Orlando
Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy [see comment]. Arthritis Rheum 34(10):1218–1227
Fournie B, Crognier L, Arnaud C, Zabraniecki L, Lascaux-Lefebvre V, Marc V et al (1999) Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. Rev Rhum (Engl Ed) 66(10):446–456
Biondi Oriente C, Scarpa R, Pucino A, Oriente P (1989) Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Derm Venereol Suppl (Stockh) 146:69–71
Helliwell P, Marchesoni A, Peters M, Barker M, Wright V (1991) A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 30(5):339–345
Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33(9):834–839
Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C (1991) Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 30(4):245–250
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673
Taylor WJ, Marchesoni A, Arreghini M, Sokoll K, Helliwell PS (2004) A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum 34(3):575–584
Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57(8):1560–1563
Wright V (1959) Rheumatism and psoriasis: a re-evaluation. Am J Med 27:454–462
Veale D, FitzGerald O (1992) Psoriatic arthritis—“DIP or not DIP? That is the question”. Br J Rheumatol 31(6):430–431
Khan M, Schentag C, Gladman DD (2003) Clinical and radiological changes during psoriatic arthritis disease progression. J Rheumatol 30(5):1022–1026
Bennett AN, McGonagle D, O, Connor P, Hensor E, Coates LC, Emery P et al (2008) Early inflammatory back pain and MRI sacroiliitis: severity of osteitis at baseline and HLA B27 predict ankylosing spondylitis at 8 years. Rheumatology 47(S2):ii5 (abstract)
Williamson L, Dockerty JL, Dalbeth N, McNally E, Ostlere S, Wordsworth BP (2004) Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology (Oxford) 43(1):85–88
Gladman DD, Anhorn KA, Schachter RK, Mervart H (1986) HLA antigens in psoriatic arthritis. J Rheumatol 13(3):586–592
McHugh NJ, Laurent MR, Treadwell BL, Tweed JM, Dagger J (1987) Psoriatic arthritis: clinical subgroups and histocompatibility antigens. Ann Rheum Dis 46(3):184–188
Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E (1999) Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 38(4):332–337
Kane D, Stafford L, Bresnihan B, FitzGerald O (2003) A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis—‘DIP or not DIP revisited’. Rheumatology (Oxford) 42(12):1469–1476
Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A et al (2002) Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 61(10):895–904
Wakefield RJ, Green MJ, Marzo-Ortega H, Conaghan PG, Gibbon WW, McGonagle D et al (2004) Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Ann Rheum Dis 63(4):382–385
Gladman DD, Farewell VT, Nadeau C (1995) Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 22(4):675–679
Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T et al (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2013–2020
Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C et al (2005) Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 64(8):1150–1157
Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial [see comment]. Lancet 356(9227):385–390
Korendowych E, Dixey J, Cox B, Jones S, McHugh N (2003) The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J Rheumatol 30(1):96–101
Ho PY, Barton A, Worthington J, Plant D, Griffiths CE, Young HS et al (2007) Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis 67:677–682
Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N (2005) The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford) 44(8):1056–1060
Taylor WJ, Zmierczak HG, Helliwell PS (2005) Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis. J Rheumatol 32(6):974–977
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coates, L.C., Helliwell, P.S. Classification and categorisation of psoriatic arthritis. Clin Rheumatol 27, 1211–1216 (2008). https://doi.org/10.1007/s10067-008-0947-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-008-0947-4